Comparative analysis and meta-analysis of major clinical trials with oral factor Xa inhibitors versus warfarin in atrial fibrillation

OBJECTIVES: A comparative analysis of three major clinical trials with factor Xa inhibitor oral anticoagulant (XOAC) drugs versus warfarin in atrial fibrillation—Rocket-AF (rivaroxaban), Aristotle (apixaban) and Engage AF Timi 48 (edoxaban; two different doses and sets of data)—was carried out. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, José Pedro L, Rodrigues, Rui Paulo, Gonçalves, Francisco Rocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189339/
https://www.ncbi.nlm.nih.gov/pubmed/25332806
http://dx.doi.org/10.1136/openhrt-2014-000080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189339/
https://www.ncbi.nlm.nih.gov/pubmed/25332806
http://dx.doi.org/10.1136/openhrt-2014-000080

Ejemplares similares